Keith M. Olsen, Pharm.D., FCCP, FCCM

Professor and Chairman

Department of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
986045 Nebraska Medical Center
Omaha, NE 68198-6045
402-559-9016 (Office)
402-559-8623 (Lab)
401-559-5673 (Fax)
kolsen@unmc.edu
 
Teaching Activities:
Dr. Olsen specializes in critical care and infectious diseases. He not only teaches in these areas but also serves as the Infectious Disease Section Coordinator for Pharmacotherapy II (PHPR 686).  Dr. Olsen is a preceptor for the critical care and infectious diseases clerkships.
 
Research Activities/Interests: 
Dr. Olsen's interest is in Critical Care research with an emphasis on ICU infections and acid suppression.
 
Recent Publications: 

  1. Bogard KN, Perterson NT, Plumb TJ, Erwin MW, Fuller PD, Olsen KM. Antibiotic dosing during sustained low-efficiency dialysis special considerations in adult critically ill patients. Special considerations in critically ill patients. Critical Care Medicine 2011;39:560-570
  2. Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM.  Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. Journal of Clinical Microbiology 2011;49(1):269-274.
  3. Lat I, Micek S, Janzen J, Cohen H, Olsen KM, Haas C. ­Off-label Medication Use in Adult Critical Care Patients. Journal of Critical Care; 2011;26:89-94.
  4. Metz DC, Fulda G, Olsen KM, Monyak JT, Simonson S, Sostek MB. Rapid onset of      intragastric acid control with intravenous esomeprazole in critically ill patients. Current Medical Research and Opinion 2010;26:1141-1148.
  5. Ng TMH, Olsen KM, McCartan MA, Speidel KM, Miller MA. Pharmacologic predictors of QTc prolongation and proarrhythmia in the adult medical intensive care unit. Journal of Pharmacy Practice 2010;23:19-24.
  6. McGuire TR, Dobesh PP, Rupp ME, Olsen KM. Clinically important interaction between statin drugs and Clostridium difficille toxin. Medical Hypothesis 2009; 73;1045-1047.
  7. Olsen KM, Hitzeman ML. Dexlansoprazole MR in the management of gastroesophageal reflux disease. Clinical Medicine: Therapeutics 2009;1:1641-1652.
  8. Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM. Statins reduce mortality in septic patients. Pharmacotherapy 2009;29:621-630.
  9. Olsen KM, Devlin JW. Comparison of Enteral and Intravenous Lansoprazole Pharmacodynamic Response in Critically Ill Patients. Alimentary Pharmacology and Therapeutics 2008; 28:326-333.
  10. Olsen KM, Gentry-Nielsen MJ, Preheim LC. Effect of Ethanol on the Efficacy of Levofloxacin, Moxifloxacin and Trovafloxacin in a Pneumococcal Pneumonia Model. Antimicrobial Agents and Chemotherapy. 2006; 50(1): 210-219.

Keith Olsen, Pharm.D.
Dr. Olsen
;